These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7670051)

  • 1. [Some features of action of "murine" toxin and Yersinia pestis antigen fraction I in cells sensitive to animal plague].
    Aseeva LE; Mishan'kin MB; Goncharov EK; Shevchenko LA
    Biull Eksp Biol Med; 1995 Feb; 119(2):193-5. PubMed ID: 7670051
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation of monoclonal antibody to V antigen from Yersinia pestis.
    Sato K; Nakajima R; Hara F; Une T; Osada Y
    Contrib Microbiol Immunol; 1991; 12():225-9. PubMed ID: 1935094
    [No Abstract]   [Full Text] [Related]  

  • 3. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.
    Glynn A; Roy CJ; Powell BS; Adamovicz JJ; Freytag LC; Clements JD
    Infect Immun; 2005 Aug; 73(8):5256-61. PubMed ID: 16041052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection and characterization of the plasmids of the plague microbe which determine the synthesis of pesticin I, fraction I antigen and "mouse" toxin exotoxin].
    Protsenko OA; Anisimov PI; Mozharov OT; Konnov NP; Popov IuA
    Genetika; 1983 Jul; 19(7):1081-90. PubMed ID: 6194044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yersinia outer proteins (YOPS) E, K and N are antigenic but non-protective compared to V antigen, in a murine model of bubonic plague.
    Leary SE; Griffin KF; Galyov EE; Hewer J; Williamson ED; Holmström A; Forsberg A; Titball RW
    Microb Pathog; 1999 Mar; 26(3):159-69. PubMed ID: 10089156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen.
    Garmory HS; Freeman D; Brown KA; Titball RW
    Vaccine; 2004 Feb; 22(8):947-57. PubMed ID: 15161071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-V antigen antibody protects macrophages from Yersinia pestis -induced cell death and promotes phagocytosis.
    Weeks S; Hill J; Friedlander A; Welkos S
    Microb Pathog; 2002 May; 32(5):227-37. PubMed ID: 12071679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reaction of macrophage disappearance as a method for the evaluation of cellular immunity in experimental plague.
    Vasilieva GI; Kisileva AK; Doroshenko YP; Pustovalov VL
    J Hyg Epidemiol Microbiol Immunol; 1992; 36(1):123-8. PubMed ID: 1619289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.
    Leary SE; Griffin KF; Garmory HS; Williamson ED; Titball RW
    Microb Pathog; 1997 Sep; 23(3):167-79. PubMed ID: 9281474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attachment of LcrV from Yersinia pestis at dual binding sites to human TLR-2 and human IFN-gamma receptor.
    Abramov VM; Khlebnikov VS; Vasiliev AM; Kosarev IV; Vasilenko RN; Kulikova NL; Khodyakova AV; Evstigneev VI; Uversky VN; Motin VL; Smirnov GB; Brubaker RR
    J Proteome Res; 2007 Jun; 6(6):2222-31. PubMed ID: 17441749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small protective fragments of the Yersinia pestis V antigen.
    Vernazza C; Lingard B; Flick-Smith HC; Baillie LW; Hill J; Atkins HS
    Vaccine; 2009 May; 27(21):2775-80. PubMed ID: 19366573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of a vaccinal strain of Yersinia pestis on lysosome fusion with phagosomes in peritoneal and alveolar macrophages].
    Vasil'eva GI; Kiseleva AK; Doroshenko EP
    Tsitologiia; 1993; 35(6-7):105-8. PubMed ID: 8266559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The characterization of the protective properties of antiplague preparations by using the index of macrophage subpopulation redistribution].
    Vasil'eva GI; Tkachenko LN; Verkina LM; Doroshenko EP
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):94-6. PubMed ID: 7879567
    [No Abstract]   [Full Text] [Related]  

  • 15. [The biochemical aspects of the pathogenicity of the causative agent of plague].
    Naumov AV; Kuz'michenko IA; Taranenko TM; Korovkin SA; Ermakova GV
    Med Parazitol (Mosk); 1995; (4):17-22. PubMed ID: 8587511
    [No Abstract]   [Full Text] [Related]  

  • 16. The action of the Yersinia pestis phage on the plague envelope antigen and the human erythrocytes.
    Kunikowska D; Głośnicka R
    Bull Inst Marit Trop Med Gdynia; 1985; 36(1-4):103-15. PubMed ID: 3841818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular detection of Yersinia pestis isolates of Indian origin by using Pla specific monoclonal antibodies.
    Mahesh S; Shukla J; Tuteja U; Batra HV
    Comp Immunol Microbiol Infect Dis; 2005 Mar; 28(2):131-44. PubMed ID: 15582689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of Yersiniae.
    Mazigh D; Quilici ML; Mollaret HH
    Contrib Microbiol Immunol; 1987; 9():304-11. PubMed ID: 3665511
    [No Abstract]   [Full Text] [Related]  

  • 19. [The isolation and characteristics of variant plague microbes not producing the capsular antigen].
    Gvozdenko NA; Ryzhkov VIu; Pavlovich NV
    Mikrobiol Zh (1978); 1990; 52(6):13-7. PubMed ID: 2097497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Yersinia pestis V antigen in attenuated salmonella typhimurium: development of a novel vaccine for plague.
    Leary SE; Eley SM; Williamson ED; Titball RW
    Contrib Microbiol Immunol; 1995; 13():216-7. PubMed ID: 8833838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.